鄰近類別 會議論文/會議摘要 [1/1] 類別統計 近3年內發表的文件:6(17.65%) 含全文筆數:34(100.00%) 文件下載次數統計 下載大於0次:34(100.00%) 下載大於100次:31(91.18%) 檔案下載總次數:11907(96.35%) 最後更新時間: 2024-11-28 18:57 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Neuroprotective effects of psilocyb... DPP-4 inhibitors sitagliptin and PF... Sitagliptin elevates plasma and CSF... Peptide immunization against the C-... Prosaposin PS18 reduces dopaminergi... Herbal formula PM012 induces neurop... Alleviation of methamphetamine snsi... Human milk oligosaccharide 2′-fucos... Administration of AAV-alpha synucle... Naltrexone is neuroprotective again...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 34. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-10-08	Neuroprotective effects of psilocybin in a rat model of stroke	BMC Neuroscience. 2024 Oct 08;25:Article number 49.
2024-04-04	DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease	GeroScience. 2024 Apr 04;Article in Press.
2024-03-27	Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: Relevance for neurodegenerative disorders	GeroScience. 2024 Mar 27;Article in Press.
2023-09-21	Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein	PLoS ONE. 2023 Sep 21;18(9):Article number e0291927.
2023-05-19	Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease	Scientific Reports. 2023 May 19;13:Article number 8148.
2023-02-22	Herbal formula PM012 induces neuroprotection in stroke brain	PLoS ONE. 2023 Feb 22;18(2):Article number e0281421.
2021-11-08	Alleviation of methamphetamine snsitization by partially lesioning dopaminergic terminals with 6-hydroxydopamine in nucleus accumbens	Cell Transplantation. 2021 Nov 8;30:Article in Press.
2021-09-13	Human milk oligosaccharide 2′-fucosyllactose induces neuroprotection from intracerebral hemorrhage stroke	International Journal of Molecular Sciences. 2021 Sep 13;22(18):Article number 9881.
2021-07	Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice	CNS Neuroscience & Therapeutics. 2021 Jul;27(7):831-841.
2021-06-21	Administration of AAV-alpha synuclein NAC antibody improves locomotor behavior in rats overexpressing alpha synuclein	Genes. 2021 Jun 21;12(6):Article number 948.
2020-10	Human milk Oligosaccharide 2 '-Fucosyllactose reduces neurodegeneration in stroke brain	Translational Stroke Research. 2020 Oct;11:1001-1011.
2020-09-25	Protective effect of CXCR4 antagonist CX807 in a rat model of hemorrhagic stroke	International Journal of Molecular Sciences. 2020 Sep 25;21(19):Article number 7085.
2020-08-11	PT320, sustained-release exendin-4, mitigates L-DOPA-Induced dyskinesia in a rat 6-Hydroxydopamine model of Parkinson’s disease	Frontiers in Neuroscience. 2020 Aug 11;14:Article number 785.
2020-03-11	Downregulation of alpha-synuclein protein levels by an intracellular single-chain antibody	Journal of Parkinson's Disease. 2020 Mar 11;10(2):573-590.
2020-02-21	Post-treatment with posiphen reduces endoplasmic reticulum stress and neurodegeneration in stroke brain	iScience. 2020 Feb 21;23(2):Article number 100866.
2019-08	Pifithrin-alpha reduces methamphetamine neurotoxicity in cultured dopaminergic neurons	Neurotoxicity Research. 2019 Aug;36(2 SI):347-356.
2019-07	Enhanced survival of human-induced pluripotent stem cell transplant in parkinsonian rat brain by locally applied cyclosporine	Brain Circulation. 2019 Jul-Sep;5(3):130-133.
2019-05-30	NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats	Brain Research. 2019 May 30;1719:124-132.
2018-11	Neuroprotective action of human Wharton's Jelly-Derived mesenchymal stromal cell transplants in a rodent model of stroke	Cell Transplantation. 2018 Nov;27(11):1603-1612.
2018-07-16	Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease	Scientific Reports. 2018 Jul 16;8:Article number 10722.
2018-07-16	Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease [Erratum: Scientific Reports. 2018 Jul 16;8:Article number 10722.]	Scientific Reports. 2018 Jul 16;8:Article number 13953.
2018-07	Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury	Brain Circulation. 2018 Jul-Sep;4(3):124-127.
2017-09	Improving neurorepair in stroke brain through endogenous neurogenesis-enhancing drugs	Cell Transplantation. 2017 Sep;26(9):1596-1600.
2017-07	9-cis retinoic acid induces neurorepair in stroke brain	Scientific Reports. 2017 Jul;7:Article number 4512.
2017-04	A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain	Cell Transplantation. 2017 Apr;26(4):571-583.

顯示項目1-25 / 34. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目